Drug intelligence / Profile preview

3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine

Development stage
Unknown
Modality
Small Molecules
01

Overview

**3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine** is a synthetic small molecule belonging to the phenylpiperazine class of organic compounds[2][4][5]. It has been studied primarily as an antiviral agent, notably for its ability to bind to the coat protein of human rhinovirus 14, suggesting potential as an inhibitor of viral entry or uncoating[3]. The compound is referenced in structural biology studies (PDB accession code: 1R09), where it was complexed with rhinovirus proteins. There are no known approved therapeutic indications or marketed products containing this compound. Its mechanism of action is presumed to involve interaction with viral capsid proteins, but detailed pharmacological data and clinical development status are not available in public databases.

Other names
3-Methoxy-6-(4-(3-methylphenyl)-1-piperazinyl)pyridazinePyridazine, 3-methoxy-6-(4-(3-methylphenyl)-1-piperazinyl)-HK76HE61AQ (UNII)CHEBI:43659
02

Targets

Human rhinovirus capsid protein

Beyond the preview

Go deeper on 3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-methoxy-6-[4-(3-methylphenyl)-1-piperazinyl]pyridazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call